Try our Advanced Search for more refined results
ÃÛÌÒÊÓÆµ
-
May 30, 2025
3rd Circ. Preview: Tribal Immunity Limits On Deck For June
The Third Circuit's June argument lineup will find a finance company fighting a proposed class action over allegedly predatory payday loan fees because of its tribal ties, while a plumbing company argues that it does not have to arbitrate a union grievance.
-
May 29, 2025
AstraZeneca Inks $51.4M Settlement In Pay-For-Delay Case
AstraZeneca Pharmaceuticals LP and Handa Pharmaceuticals LLC have agreed to shell out a combined $51.4 million to put to rest allegations AstraZeneca paid off generic-drug makers, including Handa, to protect its brand antipsychotic drug Seroquel XR, according to a filing Thursday in Delaware federal court.
-
May 29, 2025
Samsung Ends Smartwatch IP Fight With Researchers
Samsung asked a Texas federal judge to permanently dismiss its patent dispute with a group of academic research institutions over claims that the company's Galaxy smartwatches rely on their algorithms to detect irregular heartbeats and measure other physiological health markers, according to a joint motion filed Wednesday.
-
May 29, 2025
Judge Finds Epic Verdict Means One Patent Claim Invalid
A Washington federal judge has found that part of a jury's decision clearing Epic Games Inc. of patent infringement through its Fortnite game platform meant that one of the claims in the patent wasn't patent eligible.
-
May 29, 2025
​​​​​​​Netflix's 'Broad' IP Claims Against Broadcom Face Skepticism
A California federal judge appeared open Thursday to tossing some claims in Netflix's lawsuit accusing Broadcom of ripping off five software patents, repeatedly questioning how Netflix's patents improve technology and calling certain terms "incredibly broad and undefined," while also observing that Netflix's willful infringement claim may amount to "good lawyering."
-
May 29, 2025
Atty Urges 2nd Circ. To Resurrect Name Feud With Ex-Firm
A lawyer has asked the Second Circuit to revive claims against his former firm, which he alleges used his name and likeness after he was fired, saying a judge's dismissal of those claims ignored the harm he personally suffered and the requirements of the Lanham Act.
-
May 29, 2025
Ex-Copyright Chief Wants Fast Ruling In Trump Firing Dispute
The fired director of the U.S. Copyright Office asked a D.C. federal court Thursday for expedited briefing in her lawsuit challenging her termination by the Trump administration, saying there is "a pressing need" to resolve the matter quickly.
-
May 29, 2025
Columbia Sportswear Gets Mixed Trade Secrets Ruling
An Oregon federal judge has partially sided with motions by Columbia Sportswear Co. and a former employee in a case alleging the worker took trade secrets with him when he left the company, but denied the bulk of the requests from all parties seeking to end the suit in their favor.
-
May 29, 2025
Epic Seeks More Interest On Tata's $140M Punitive Award
Epic Systems argued Thursday that the Seventh Circuit should order a lower court to recalculate its post-judgment interest on a $140 million punitive damages award against Tata Group because interest should have run from its original 2017 judgment rather than the amended version entered five years later.
-
May 29, 2025
Ex-USPTO Solicitor Says He's Against Squires Nomination
A former solicitor for the U.S. Patent and Trademark Office has come out against the nomination of John A. Squires to be the next director of the agency, saying in a letter Thursday that he's concerned about the nominee's desire to make existing patents stronger.
-
May 29, 2025
Cannabis Package Maker Alleges Trademark Infringement
A manufacturer of packaging designed for cannabis products alleged in a lawsuit filed Thursday in Oklahoma federal court that a competitor has been infringing its designs and trademarks with knockoff wares.
-
May 29, 2025
Ex-United Therapeutics Exec Can't Dodge IP Suit
A former United Therapeutics Corp. executive lost his bid to toss his former employer's suit alleging he used stolen intellectual property to develop a lung disease drug for a competitor, with the North Carolina Business Court ruling that it was too soon to determine if the complaint was untimely.
-
May 29, 2025
Cochlear Implant Rivals Call Truce Ahead Of UPC Ruling
Two cochlear implant heavyweights have quietly settled their global patent dispute, with both parties agreeing to dismiss a U.S. appeal on Thursday, bringing an abrupt end to the transatlantic clash.
-
May 29, 2025
Judge Keeps Betting-Tech Suit On Track As Sanctions Loom
A Nevada federal judge refused a sportsbook technology company's attempt to stay briefings on a motion for sanctions in its trade secrets suit against a former collaborator, ruling the request lacks sufficient justification.
-
May 29, 2025
Qualcomm Can't Duck IP Suit Over Snapdragon Processors
A Texas federal court on Thursday refused to throw out a suit claiming Qualcomm Inc.'s processors infringe a microcontroller patent, finding that it's too early to resolve a dismissal bid and other issues should be worked out first.
-
May 29, 2025
Apple Says Google Ruling Boosts Appeal Of $300M Verdict
Apple has told the Federal Circuit that its en banc decision ordering a new damages trial in a separate suit against Google bolsters its own appeal of a $300 million verdict against the tech giant for infringing standard-essential 4G patents owned by Optis.
-
May 29, 2025
Disney Can't Stop Brazil Court Injunction In IP Row, For Now
A California federal judge has denied The Walt Disney Co.'s request to block a Brazilian court from taking injunctive action against it in a patent dispute with wireless technology developer InterDigital Inc., saying the entertainment giant has not shown it's likely the Brazilian court will issue a preliminary injunction barring the use of certain video codec technology.
-
May 29, 2025
Intel Convinces Texas Jury That Fortress Controls VLSI
A Texas federal jury on Thursday found that Fortress Investment Group controls both VLSI Technology and Finjan Holdings, and a judge will now decide whether that means Intel can escape findings that it infringed VLSI's patents by invoking its license with Finjan.
-
May 29, 2025
NYT, Amazon Reach Licensing Deal To Use Content For AI
The New York Times and Amazon have reached a licensing deal for the tech and online retail giant to use the newspaper's editorial content on its artificial intelligence platforms, the companies announced Thursday.
-
May 28, 2025
Intel Pushes Fortress, VLSI On Financial Control Limits
Intel Corp. tried to convince an Austin federal jury Wednesday that Fortress Investment Group's power to say "no" when VLSI Technology LLC requests money, among other override authorities, makes clear who has actual control over VLSI's finances, even if that "no" has never been invoked.
-
May 28, 2025
LADS Copyright Registration Error Revives Suit Against Agilis
The Eighth Circuit on Wednesday revived LADS Network Solutions Inc.'s lawsuit accusing Agilis Systems LLC of infringing its copyrighted software, saying there is a "genuine dispute" on whether inaccurate information in LADS copyright registration makes it invalid.
-
May 28, 2025
Judge Says Nokia Might Have License In AT&T 5G Patent Case
A Texas federal magistrate judge has recommended that the Eastern District of Texas reject an Irish company's effort to defeat Nokia's argument that it couldn't have infringed a telecommunications patent because it has a license from the patent's former owner.
-
May 28, 2025
5 Federal Circuit Clashes To Watch In June
The Federal Circuit will hear cases in June that include an attempt to revive and expand a discarded $64 million trade secrets judgment against Goodyear, and a dispute between drugmakers Acorda and Alkermes that asks when licensees who pay royalties on expired patents can get a refund in arbitration.
-
May 28, 2025
Execs Smuggled Billions In Goods To Skirt Duties, Feds Say
Two California shipping company executives have been charged with smuggling billions of dollars' worth of goods from the United States into Mexico — avoiding millions of dollars in duties to Mexico — using bogus documents, shell companies, bribes to public officials and kickbacks to drug cartels.
-
May 28, 2025
Fla. Judge Told Pharma Co. Rival Also Stole Trade Secrets
A Florida federal judge on Wednesday denied an India-based pharmaceutical company's bid to reject a competitor's defense against a lawsuit alleging trade secrets theft by claiming its accuser is responsible for the same conduct, expressing doubt whether she can rule on such an issue.
Expert Analysis
-
How Amended Rule 702 Affects Testimony In Patent Litigation
In 2023, Federal Rule of Evidence 702 was amended to address the apparent failure of some courts to prevent unreliable expert evidence from reaching a jury, but a statistical analysis of Daubert decisions in 2022 and 2024 shows that courts remain divided about how to apply consistent evidence standards, say attorneys at Perkins Coie.
-
4 Ways Women Attorneys Can Build A Legal Legacy
This Women’s History Month, women attorneys should consider what small, day-to-day actions they can take to help leave a lasting impact for future generations, even if it means mentoring one person or taking 10 minutes to make a plan, says Jackie Prester, a former shareholder at Baker Donelson.
-
Navigating The Growing Thicket Of 'Right To Repair' Laws
An emerging patchwork of state laws on the right to repair creates tensions with traditional intellectual property and competition principles, so manufacturers should plan proactively for legal disputes and minimize potential for rival third-party repairs to weaponize state laws, say attorneys at Reed Smith.
-
A Judge's Pointers For Adding Spice To Dry Legal Writing
U.S. District Judge Fred Biery shares a few key lessons about how to go against the grain of the legal writing tradition by adding color to bland judicial opinions, such as by telling a human story and injecting literary devices where possible.
-
Preparing For Disruptions To Life Sciences Supply Chains
Life sciences companies must assess how new and escalating tariffs — combined with other restrictions on cross-border activity singling out pharmaceutical products and medical devices — will affect supply chains, and they should proactively prepare for antitrust and foreign direct investment regulatory review processes, say attorneys at Weil.
-
Beware Risks Of Arguing Multiple Constructions In IP Cases
Defendants accused of patent infringement often argue for different, potentially contradictory, claim constructions before district courts and the Patent Trial and Appeal Board, but the board may be clamping down on this strategy, say attorneys at Dechert.
-
Unpacking Liability When AI Makes A Faulty Decision
As artificial intelligence systems become more autonomous and influential in decision-making, concerns about AI-related harms and problematic decisions are growing, raising the pressing question of who bears the liability, says Megha Kumar at CyXcel.
-
How To Create A Unique Jury Profile For Every Case
Instead of striking potential jurors based on broad stereotypes or gut feelings, trial attorneys should create case-specific risk profiles that address the political climate, the specific facts of the case and the venue in order to more precisely identify higher-risk jurors, says Ken Broda-Bahm at Persuasion Strategies.
-
IRS Scrutiny May Underlie Move Away From NIL Collectives
The University of Colorado's January announcement that it was severing its partnership with a name, image and likeness collective is part of universities' recent push to move NIL activities in-house, seemingly motivated by tax implications and increased scrutiny by the Internal Revenue Service, say attorneys at Buchanan Ingersoll.
-
6th Circ. Ruling Paves Path Out Of Loper Bright 'Twilight Zone'
The U.S. Supreme Court’s Loper Bright ruling created a twilight zone between express statutory delegations that trigger agency deference and implicit ones that do not, but the Sixth Circuit’s recent ruling in Moctezuma-Reyes v. Garland crafted a two-part test for resolving cases within this gray area, say attorneys at Wiley.
-
A Reminder On Avoiding Improper Venues In Patent Cases
A Texas federal court's recent decision in the Symbology and Quantum cases shows that baseless patent venue allegations may be subject to serious Rule 11 sanctions, providing venue-vetting takeaways for plaintiffs and defendants, say attorneys at Bond Schoeneck.
-
Opinion
NCAA Name, Image, Likeness Settlement Is A $2.8B Mistake
While the plaintiffs in House v. NCAA might call the proposed settlement on name, image and likeness payments for college athletes a breakthrough, it's a legally dubious Band-Aid that props up a system favoring a select handful of male athletes at the expense of countless others, say attorneys at Clifford Chance.
-
Copyright Ruling Could Extend US Terminations Worldwide
If upheld on appeal, Vetter v. Resnik, a recent ruling from a Louisiana federal court, could extend the geographical scope of U.S. copyright termination rights to foreign territories, say attorneys at Manatt.
-
NIH Cuts To Indirect Costs May Stifle IP Generation
Although currently blocked by a preliminary injunction, the National Institutes of Health's new policy to cut down on indirect cost funding creates challenges for university research projects, and may hamper the development of intellectual property — which is considered an indirect cost — for years to come, say attorneys at Snell & Wilmer.
-
Bankruptcy Ruling Provides Guidance On 363 Asset Sales
HE v. Avadim Holdings, a recent ruling from the District of Delaware, underscores the principle that rejection of executory contracts does not unwind completed transfers of property and the importance of clear and precise language in sale orders and asset purchase agreements in bankruptcy cases, say attorneys at Eversheds Sutherland.